LOVE

Lovesac is a deteriorating business trading at a value price, and the two facts nearly cancel out. Revenue has flatlined near $700M for three years (+2.4% in FY2026 to $697M), but the earnings power underneath has eroded relentlessly: net income has fallen every single year from $47.5M (FY2022) to $26.5M, $23.9M, $11.6M, and now just $4.07M — a 65% drop this year alone, dragging EPS to $0.28 and ROE to 1.9%. The MD&A pins the pain squarely on tariffs: gross margin fell 210bps to 56.4% as inbound transportation and tariff costs added 180bps, and management's mitigation plan (US domestic manufacturing, vendor concessions) is explicitly flagged as an unproven risk factor. Operating margin has cratered from 4.4% (FY2024) to 0.8%. This is a real, multi-year quality decline, not a one-off.

The offset is the balance sheet and cash generation, which are far healthier than the P/E of 62.5 suggests. Cash grew 21.6% to $101.9M against a market cap of just $256M, and there is no long-term debt on the FY2026 balance sheet (the $78M last shown was back in FY2021). The 1.44x liabilities/equity is dominated by leases and payables, not borrowings. Critically, operating cash flow rose 26.6% to $49.3M — more than 12x reported net income, thanks to D&A and working-capital swings — leaving roughly $26M of free cash after $23.1M capex. Strip out the $102M cash and the enterprise trades near 6x free cash flow. P/S of 0.4 on a brand with 56% gross margins is genuinely cheap, and the stock at $17.49 is a fraction of its former self.